MS drug pregnancy risks under scrutiny in major study
NCT ID NCT05688436
Summary
This study aims to understand the safety of the MS medication diroximel fumarate during pregnancy. Researchers will compare pregnancy outcomes and baby health across three groups: women who took this drug, those who took other MS medications, and those who took no MS medications during pregnancy. The study is observational, meaning it collects health information without changing treatment, and will follow participants through pregnancy and their babies' first year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
OptumInsight
RECRUITINGEden Prairie, Minnesota, 55344-2503, United States
Contact
Conditions
Explore the condition pages connected to this study.